The future of adjuvant therapy in ampullary cancer: should we offer it to our patients?
作者信息
Tella Sri Harsha, Mahipal Amit
机构信息
Department of Internal Medicine, University of South Carolina School of Medicine, Columbia, SC, USA.
Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
出版信息
Hepatobiliary Surg Nutr. 2020 Jun;9(3):368-370. doi: 10.21037/hbsn.2019.11.06.
Abstract
摘要
相似文献
1
The future of adjuvant therapy in ampullary cancer: should we offer it to our patients?壶腹癌辅助治疗的未来：我们应该为患者提供这种治疗吗？
Hepatobiliary Surg Nutr. 2020 Jun;9(3):368-370. doi: 10.21037/hbsn.2019.11.06.
2
Adjuvant radiotherapy following pancreaticoduodenectomy for ampullary adenocarcinoma improves survival in node-positive patients: a propensity score analysis.胰十二指肠切除术治疗壶腹腺癌术后辅助放疗可提高淋巴结阳性患者的生存率：倾向评分分析。
Clin Transl Oncol. 2018 Sep;20(9):1212-1218. doi: 10.1007/s12094-018-1849-9. Epub 2018 Mar 1.
3
4
Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.上皮细胞黏附分子（Ep-CAM）在胰腺癌和壶腹癌中的表达：频率及预后相关性
J Clin Pathol. 2008 Jan;61(1):31-5. doi: 10.1136/jcp.2006.037333. Epub 2006 Jun 14.
5
Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas.胰十二指肠切除术的结果及辅助治疗对壶腹癌的影响。
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):945-53. doi: 10.1016/s0360-3016(00)00537-x.
6
Adjuvant chemo-radiotherapy in ampullary cancers.壶腹癌的辅助放化疗
Eur J Surg Oncol. 2005 Mar;31(2):158-63. doi: 10.1016/j.ejso.2004.08.013.
7
Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.CD44 异构体在壶腹腺癌中的双重作用：CD44s 预示早期癌症预后不良，而 CD44ν 是晚期癌症复发的一个指标。
BMC Cancer. 2015 Nov 16;15:903. doi: 10.1186/s12885-015-1924-3.
8
Matrix metalloproteinase 7 expression in ampullary carcinoma.壶腹癌中基质金属蛋白酶7的表达
Indian J Pathol Microbiol. 2015 Jul-Sep;58(3):274-8. doi: 10.4103/0377-4929.162830.
9
Ampullary cancer--a separate clinical entity?壶腹癌——一个独立的临床实体？
Histopathology. 2014 May;64(6):759-68. doi: 10.1111/his.12324. Epub 2014 Jan 24.
10
Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer.壶腹癌根治性切除术后接受辅助放化疗患者淋巴结比率的预后意义
Am J Clin Oncol. 2016 Aug;39(4):346-9. doi: 10.1097/COC.0000000000000075.
引用本文的文献
1
Clinical and molecular characteristics of periampullary carcinoma based on pathological subtypes.基于病理亚型的壶腹周围癌的临床和分子特征
J Gastrointest Oncol. 2025 Feb 28;16(1):249-263. doi: 10.21037/jgo-2025-14. Epub 2025 Feb 26.
2
Remission from the 5-Fu-Based Chemotherapy to Gemcitabine-Based Chemotherapy-Based on the Pathological Classification of Periampullary Carcinoma: A Case Report and Literature Review.基于壶腹周围癌病理分类的5-氟尿嘧啶化疗至吉西他滨化疗的缓解：一例报告及文献综述
Onco Targets Ther. 2022 Aug 25;15:891-896. doi: 10.2147/OTT.S372053. eCollection 2022.
3
Adjuvant therapy for periampullary carcinoma and the significance of histopathological typing: A systematic review.壶腹周围癌的辅助治疗及组织病理学分型的意义：一项系统综述
Transl Oncol. 2022 Jun;20:101414. doi: 10.1016/j.tranon.2022.101414. Epub 2022 Apr 6.
本文引用的文献
1
Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.辅助多模态治疗在壶腹癌根治性切除术后的作用。
JAMA Surg. 2019 Aug 1;154(8):706-714. doi: 10.1001/jamasurg.2019.1170.
2
Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.壶腹癌：体细胞和种系遗传改变的评估及其与临床结果的关联。
Cancer. 2019 May 1;125(9):1441-1448. doi: 10.1002/cncr.31951. Epub 2019 Jan 8.
3
Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.胰十二指肠切除术治疗壶腹腺癌的预后因素和辅助治疗的获益：梅奥诊所经验。
Eur J Surg Oncol. 2018 May;44(5):677-683. doi: 10.1016/j.ejso.2018.02.008. Epub 2018 Feb 16.
4
Association of Adjuvant Therapy with Improved Survival in Ampullary Cancer: A National Cohort Study.辅助治疗与壶腹癌生存改善相关：一项全国性队列研究。
J Gastrointest Surg. 2018 Apr;22(4):695-702. doi: 10.1007/s11605-017-3624-6. Epub 2017 Nov 10.
5
Ampullary cancer: an overview.壶腹癌概述
Am Soc Clin Oncol Educ Book. 2014:112-5. doi: 10.14694/EdBook_AM.2014.34.112.
6
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.氟尿嘧啶+亚叶酸辅助化疗与观察对可切除的壶腹周围腺癌患者生存的影响：ESPAC-3 壶腹周围癌随机试验。
JAMA. 2012 Jul 11;308(2):147-56. doi: 10.1001/jama.2012.7352.
7
Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program.壶腹癌：基于美国监测、流行病学和最终结果（SEER）项目5625例病例的人口统计学、形态学及生存率分析
J Surg Oncol. 2009 Dec 1;100(7):598-605. doi: 10.1002/jso.21374.
8
Tumors of the ampulla of vater: histopathologic classification and predictors of survival.Vater壶腹肿瘤：组织病理学分类及生存预测因素
J Am Coll Surg. 2008 Aug;207(2):210-8. doi: 10.1016/j.jamcollsurg.2008.01.028. Epub 2008 May 5.
9
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.术后辅助化疗对胆囊癌是否有用？一项针对已切除胰胆管癌患者的III期多中心前瞻性随机对照试验。
Cancer. 2002 Oct 15;95(8):1685-95. doi: 10.1002/cncr.10831.
10
Influence of site of origin and mucin production on survival in ampullary carcinoma.壶腹癌的原发部位和黏液产生对生存的影响
Ann Surg. 1989 Aug;210(2):173-9. doi: 10.1097/00000658-198908000-00006.
Zotero 插件